Dr. Ilse Mertens, nucleaire geneeskunde SRL
Dr. Ilse Mertens, nucleaire geneeskunde reported total assets of 377,300 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jan 2026).
The score of Dr. Ilse Mertens, nucleaire geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Ilse Mertens, nucleaire geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 109,938 € | ||||
| Equity | 353,871 € | ||||
| Cash | 13,399 € | ||||
| EBITDA | 162,189 € | ||||
| Total assets | 377,300 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 31 Jan 2026
- Year ended 30 Jun 2024filed on 31 Jan 2025
- Year ended 30 Jun 2023filed on 31 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
Dr. Ilse Mertens, nucleaire geneeskunde's financial analysis
- Solvency93.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Ilse Mertens, nucleaire geneeskunde
1 active director(s) in the register.
Dr. Ilse Mertens, nucleaire geneeskunde's shareholders and holdings →Dr. Ilse Mertens, nucleaire geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0859.780.383
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0859780383 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jul 2003
- Registered office
- 1755 Pajottegem
- Latest accounts
- 2025 · filed on 31 Jan 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Ilse Mertens, nucleaire geneeskunde (SRL) has been based in Pajottegem since 2003, active in: medical specialists activities. For 2025, it reports a net profit of 109,938 € and equity of 353,871 €; its revenue is not published. Its solvency stands at 93.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Ilse Mertens, nucleaire geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Picavet Beheer Manufacture of basic pharmaceutical products Schoten · balance sheet 377,326 €
- Gleeve Manufacture of basic pharmaceutical products Destelbergen · balance sheet 377,263 €
- Morgenstern Tongeren-Borgloon · balance sheet 377,449 €
- Zakenkantoor Schepers - Poels Lummen · balance sheet 377,132 €
- DBL Invest Warehousing and storage Ghent · balance sheet 377,507 €
- Future Compta Spa · balance sheet 377,154 €
- Thuisverzorging de Leebeeck Putte · balance sheet 377,147 €
Frequently asked questions about Dr. Ilse Mertens, nucleaire geneeskunde
What is the revenue of Dr. Ilse Mertens, nucleaire geneeskunde?
Dr. Ilse Mertens, nucleaire geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Ilse Mertens, nucleaire geneeskunde?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Ilse Mertens, nucleaire geneeskunde. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0859780383. Its company number (CBE) is 0859.780.383.
Where is the registered office of Dr. Ilse Mertens, nucleaire geneeskunde?
According to the CBE register, the registered office of Dr. Ilse Mertens, nucleaire geneeskunde is in 1755 Pajottegem.
What is the equity of Dr. Ilse Mertens, nucleaire geneeskunde?
At the close of the 2025 financial year, the equity of Dr. Ilse Mertens, nucleaire geneeskunde amounts to 353,871 €, a solvency of 93.8% of total assets.
Who manages Dr. Ilse Mertens, nucleaire geneeskunde?
The register lists 1 active mandates at Dr. Ilse Mertens, nucleaire geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Ilse Mertens, nucleaire geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →